Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Free Cash Flow (2020 - 2025)

Silence Therapeutics' Free Cash Flow history spans 6 years, with the latest figure at -$17.3 million for Q4 2025.

  • On a quarterly basis, Free Cash Flow rose 37.24% to -$17.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$62.3 million, a 8.66% increase, with the full-year FY2025 number at -$62.3 million, up 8.14% from a year prior.
  • Free Cash Flow hit -$17.3 million in Q4 2025 for Silence Therapeutics, down from -$10.9 million in the prior quarter.
  • Over the last five years, Free Cash Flow for SLN hit a ceiling of $37.0 million in Q2 2021 and a floor of -$27.5 million in Q4 2024.
  • Historically, Free Cash Flow has averaged -$11.7 million across 5 years, with a median of -$12.0 million in 2021.
  • The widest YoY moves for Free Cash Flow: up 67.54% in 2024, down 314.51% in 2024.
  • Tracing SLN's Free Cash Flow over 5 years: stood at -$11.7 million in 2021, then crashed by 36.7% to -$16.1 million in 2022, then rose by 7.56% to -$14.8 million in 2023, then plummeted by 85.63% to -$27.5 million in 2024, then skyrocketed by 37.24% to -$17.3 million in 2025.
  • Business Quant data shows Free Cash Flow for SLN at -$17.3 million in Q4 2025, -$10.9 million in Q3 2025, and -$21.8 million in Q2 2025.